CORC  > 武汉大学
ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein
Wang, Guan; Zhan, Yao; Wang, Haiqing; Li, Wenhua
刊名CANCER CHEMOTHERAPY AND PHARMACOLOGY
2012
卷号69期号:3
关键词TRAIL ABT-263 Hepatocarcinoma cells Apoptosis
ISSN号0344-5704
DOI10.1007/s00280-011-1763-0
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4087604
专题武汉大学
推荐引用方式
GB/T 7714
Wang, Guan,Zhan, Yao,Wang, Haiqing,et al. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY,2012,69(3).
APA Wang, Guan,Zhan, Yao,Wang, Haiqing,&Li, Wenhua.(2012).ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.CANCER CHEMOTHERAPY AND PHARMACOLOGY,69(3).
MLA Wang, Guan,et al."ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein".CANCER CHEMOTHERAPY AND PHARMACOLOGY 69.3(2012).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace